Bluejay Diagnostics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BJDX Company Description
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
BJDX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BJDX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BJDX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BJDX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of BJDX in WallStreetBets Daily Discussion
BJDX News
Recent insights relating to BJDX
CNBC Recommendations
Recent picks made for BJDX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BJDX
Corporate Flights
Flights by private jets registered to BJDX
Our Analysis